Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR positive
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(8)
News
Trials
Search handles
@APassaroMD
@AndresFCardonaZ
@DanZhaoMD
@Dr_Ivanoncologo
@FilippoMontemu1
@HHorinouchi
@JackWestMD
@MARIANOPROVENCI
@MLPOncoData
@SimonLo21054188
@SuyogCancer
@VivekSubbiah
@bpiperdi
@dr_yakupergun
@sujithonco
@weldeiry
Search handles
@APassaroMD
@AndresFCardonaZ
@DanZhaoMD
@Dr_Ivanoncologo
@FilippoMontemu1
@HHorinouchi
@JackWestMD
@MARIANOPROVENCI
@MLPOncoData
@SimonLo21054188
@SuyogCancer
@VivekSubbiah
@bpiperdi
@dr_yakupergun
@sujithonco
@weldeiry
Filter by
Latest
9ms
Targeting both EGFR-positive tumors and PD-1 blockade may result in improved tumor shrinkage, says our Dr. Ann Gillenwater, suggesting further study to assess its potential as a new therapy for recurrent head and neck cancer. https://t.co/8AG8Cdbo05 @OncLive @agillenw #EndCancer (@MDAndersonNews)
9 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
9ms
Learn about the realities of treating EGFR positive NSCLC in Brazil from the good to the areas of improvement. @IASLC @StephenVLiu (@NarjustFlorezMD)
9 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
9ms
#LungCancerConsidered host @NarjustFlorezMD examines treatment of EGFR-positive #lungcancer in Brazil, from early-stage disease to metastatic lung cancer. W/Dr. Juliana Ominelli (Brazilian National Cancer Institute) & @victormarcondes (Oncomed Oncologia): https://t.co/Fx7NhW5NEV (@IASLC)
9 months ago
Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
9ms
New📰published: AMEERA-3: Randomized Phase II Study of Amcenestrant Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. @stolaney1 and colleagues. https://t.co/QqL6DtT4C7 (@DFCI_BreastOnc)
9 months ago
Clinical • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • EGFR positive
|
amcenestrant (SAR439859)
11ms
#ASCO Guideline Update on Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer from @DrHBurstein et al #bcsm #MBC #breastcancer (@DFCI_BreastOnc)
11 months ago
Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
11ms
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records https://t.co/cudttylMUM (@MLPOncoData)
11 months ago
Clinical • HEOR • Real-world evidence • Real-world • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Perjeta (pertuzumab)
11ms
@NarjustFlorezMD & @StephenVLiu talk w/@DrRoyHerbstYale about ADAURA Trial, which introduced targeted therapy in the adjuvant setting for early-stage EGFR positive #NSCLC, showing DFS rates never seen before & changing treatment of early-stage #lungcancer. https://t.co/83VEVSYgFc (@IASLC)
11 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
12ms
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer https://t.co/XAw4xrIpHJ (@MLPOncoData)
12 months ago
Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
12ms
New systematic review on Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive #BreastCancer and #BrainMetastases from @stolaney1 @volkmar_mueller @nlinmd @FilippoMontemu1 et al Full text⬇️: https://t.co/GTBy56oweT (@DFCI_BreastOnc)
12 months ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
almost1year
Optimal duration of adjuvant TKI? @Alfdoc2 kicked off the session truly illustrative case prese ntation! Very relevant situation and question for these patients after complete resection of EGFR positive NSCLC. #ELCC23 #LCSM @myESMO @IASLC (@HHorinouchi)
almost 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
New📰from @JournalCancer👉Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. @DrAnnaWeiss @TariKingMD @stolaney1 @PTarantinoMD https://t.co/CTl7Rgm4Xf (@DFCI_BreastOnc)
1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer An excellent review👇 @CAonline https://t.co/nghZLt5CFe (@dr_yakupergun)
1 year ago
Review • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
1year
⚡️Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts @PTarantinoMD @OncoAlert @JournalCancer @AmericanCancer https://t.co/A7Z2eUraKM (@VivekSubbiah)
1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
At #TTLC23, experts debated the pros and cons of continued TKI use with chemotherapy for EGFR-positive patients with disease progression. Read a recap in #ILCN: https://t.co/bvNZVrSbEV @DrSteveMartin #LCSM (@IASLC)
1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
@JoelNealMD MD, PhD, discussed what options physicians would choose when treating a patient with #NSCLC who tested positive for an EGFR exon 20 insertion. #lcsm | @StanfordMed https://t.co/la7vAWZlF3 (@TargetedOnc)
1 year ago
Clinical • EGFR exon 20
|
EGFR (Epidermal growth factor receptor)
|
EGFR exon 20 insertion • EGFR exon 20 mutation • EGFR positive
1year
Just Published Systematic Literature Review on the Epidemiology, Clinical Outcomes, and Unmet Needs of Patients With Human Epidermal Growth Factor Receptor 2-Positive #BreastCancer and Brain Metastases. @stolaney1 @nlinmd @volkmar_mueller @FilippoMontemu1 https://t.co/6V1NIiQ9sw (@DFCI_BreastOnc)
1 year ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Epidemiology, Clinical Outcomes, and Unmet Needs of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: A Systematic Literature Review https://t.co/kMUoXa3eIi I am so sappy to have provided my contribution, with a stellar faculty! (@FilippoMontemu1)
1 year ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Showing 1594 in #lungcancer -THIS is what happens to you egfr positive patients when you don’t identify their mutation or just go to #immunotherapy. Like chemo alone says @n8pennell @OncLive @OncLiveSOSS with chair #DrAlexAdjei @ClevelandClinic (@donnashort)
1 year ago
Clinical • IO biomarker
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data | Future Oncology https://t.co/nSW3k53kse (@MARIANOPROVENCI)
1 year ago
Clinical • Real-world evidence • Real-world
|
EGFR (Epidermal growth factor receptor)
|
EGFR T790M • EGFR positive
|
Tagrisso (osimertinib)
over1year
A New Year Gift art from a small girl She drew a picture also on doctor's day when her grandmother came to meet me for Follow up. Her grandmother has EGFR positive stage 4 lung cancer and is on Gefitinib since 2yr #KINDNESS #lungcancer (@sujithonco)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
|
gefitinib
over1year
Don't miss Dr. Sara Tolaney's talk tomorrow at #SABCS22 on Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive (HER2+) #BreastCancer: final 10-year results and correlative analyses. @stolaney1 (@DFCI_BreastOnc)
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Herceptin (trastuzumab) • paclitaxel
over1year
Can IO work post tki progression in egfr positive nsclc ? Nivo trial is negative. What about pembrolizumab ? Time will answer. By @peters_solange @myESMO #ESMOAsia22 @JackWestMD @StephenVLiu (@SuyogCancer)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
|
Keytruda (pembrolizumab) • Opdivo (nivolumab)
over1year
Prof. Ahn provided important information comparing tissue and liquid NGS in EGFR-positive NSCLC in the ELIOS trial. #ESMOAsia22 #LCSM (@HHorinouchi)
over 1 year ago
Next-generation sequencing
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Nice discussion covering broad topics in EGFR-positive NSCLC by @Alfdoc2. #ESMOAsia22 #LCSM (@HHorinouchi)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Prof. Pasi Jänne provided great summary on novel treatment strategy on EGFR positive NSCLC. Welcome back to Japan after long blank due to COVID-19. @JLCS2022 @JLCS_OFFICIAL #LCSM (@HHorinouchi)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
PD18-02 Friday @SABCSSanAntonio Adjuvant Paclitaxel and Trastuzumab Trial (APT) for node-negative, human epidermal growth factor receptor 2–positive (HER2+) breast cancer: final 10-year analysis Includes @HER2DX and other correlative analyses! Presenter: @stolaney1 ()
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
HER2DX
|
Herceptin (trastuzumab) • paclitaxel
over1year
News: Telisotuzumab vedotin plus erlotinib may offer a novel treatment option for #NSCLC positive for both EGFR and c-Met alterations, report Ross Camidge (@CUCancerCenter) @barlesi @AlexSpiraMDPhD @DavidHongMD et al in @JCO_ASCO https://t.co/7aRiUwEF6f (@MM_Oncology)
over 1 year ago
EGFR (Epidermal growth factor receptor) • MET (MET proto-oncogene, receptor tyrosine kinase)
|
EGFR positive
|
erlotinib • telisotuzumab vedotin (ABBV-399)
over1year
Cancers | Free Full-Text | Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer @VenurVyshak @drjenspecht @fredhutch @uwradonc https://t.co/Q0LQIpdpJ9 (@SimonLo21054188)
over 1 year ago
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
over1year
Dr. @ZPiotrowskaMD and I are answering ?s RIGHT NOW over on @LUNGevity's FB page as we talk about advice for patients with EGFR-positive #lungcancer. Join us! https://t.co/cGpPVDD4Oi #LCSM (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Join me and Dr. @ZPiotrowskaMD TOMORROW at 3 PM ET on @LUNGevity's FB page as we discuss advice for patients newly diagnosed with EGFR-positive #lungcancer #LCSM @EGFRResisters (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Flaura trial changed the landscape of how we treat egfr positive #lungcancer says Dr Patel with cochairs @DrHaigentz and @SalmaJabbour1 @RutgersCancer @RWJBarnabas @OncLive @OncLiveSOSS #lcsm 80% of patients saw objective response (@donnashort)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Join Dr. @ZPiotrowskaMD and me on Sept 22 at 3 pm ET as we discuss advice for patients newly-diagnosed with EGFR-positive #lungcancer. Simply go to @LUNGevity's Facebook page and tune in! @EGFRResisters #LCSM (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
For PD-L1 positive and EGFR/ALK wild type NSCLC, it is highly possible that neoadjuvant IO is better than adjuvant IO. (@JoeChangMD)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase)
|
PD-L1 expression • ALK positive • EGFR wild-type • ALK wild-type • EGFR positive
over1year
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer | Journal of Clinical Oncology @hoperugo @stolaney1 @dradityabardia @JCO_ASCO @ASCO https://t.co/2CXiFk3pwm (@bpiperdi)
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
|
Trodelvy (sacituzumab govitecan-hziy)
over1year
Afatinib in front line for uncommon mutations seem to do better for egfr positive #lungcancer says Dr Leighl with moderator @marinagarassino @gotoPER #ilcc #hb @IASLC @GO2Foundation @pmcancercentre @UCCancerCenter #lcsm use NGS (@donnashort)
over 1 year ago
Next-generation sequencing
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR positive
|
Gilotrif (afatinib)
over1year
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology https://t.co/UkQvslT2QV (@weldeiry)
over 1 year ago
HER-2 (Human epidermal growth factor receptor 2) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
|
PIK3CA mutation • EGFR positive
almost2years
5 drugs recipe 🥣. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group https://t.co/q0K5tvozxF (@m_khushman)
almost 2 years ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Herceptin (trastuzumab) • Perjeta (pertuzumab)
almost2years
Interesting review of #treatment for estrogen receptor-positive/human epidermal growth factor receptor two negative advanced #breastcancer. @oncotoracicamx @JCO_ASCO @aceveher2neu @AndresFCardonaZ @FernandoOnco @genomejunkie https://t.co/ozWrJw1OhD (@Dr_Ivanoncologo)
almost 2 years ago
Review
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • EGFR positive
almost2years
##ASCO22 Is over! #LCSM It was a great, to recap data presented on the EGFR-positive disease, with @MatthewGKrebs @nicogirardcurie & @JSabari for the post-ASCO OME forum. New evidences & results in the fields are really promising (post -Osi resistant & exon20ins disease) (@APassaroMD)
almost 2 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
almost2years
Axillary Response to #Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative #BreastCancer Patients: Predictors and #OncologicOutcomes https://t.co/xu5rCW8bD9 @Dr_Avisar @umiamimedicine #VisualAbstract @McMastersKelly (@AnnSurgOncol)
almost 2 years ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • EGFR positive
almost2years
Chaired by @BenjaminBesseMD, experts including VHIO’s @EnriquetaFelip participate in an @ecancer panel discussion on the latest in EGFR positive #NSCLC and data presented at #ASCO22 @ASCO https://t.co/LCWeKRVvus (@VHIO)
almost 2 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
almost2years
I was happy to discuss with @EnriquetaFelip , @Anna_Minchom chaired by @BenjaminBesseMD about the latest news in EGFR positive NSCLC, presented during #ASCO22 @ecancer @EGFRResisters @Exon20Group #LCSM https://t.co/fdaq35VKTT (@APassaroMD)
almost 2 years ago
EGFR exon 20
|
EGFR (Epidermal growth factor receptor)
|
EGFR exon 20 insertion • EGFR exon 20 mutation • EGFR positive
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login